Clinical trial reportCancer chemotherapy and pharmacologyPublished
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University Hospital, with Jefferson Health linked by the institution reference. Affiliation source
- Institutions
- Jefferson Health, Thomas Jefferson University Hospital
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Cancer chemotherapy and pharmacology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Colorectal Neoplasms; Neoplasm Metastasis; Quinolines; GTP Phosphohydrolases; Proto-Oncogene Proteins B-raf; Membrane Proteins; Antineoplastic Combined Chemotherapy Protocols; Mutation; Adult; Aged; Aged, 80 and over
- PubMed ID
- 40782152
- Added to directory
- Source checked